The Scientist - Home

Despite high-profile political tensions between the two countries, researchers in the US and China are working together now more than ever, according to our bibliometric study.

What we can and must do to make science more equitable.

The results, while preliminary, suggest that survivors of SARS-CoV-2 infection may be susceptible to reinfection within weeks or months.

The steroid’s exceptional performance in early results from the RECOVERY clinical trial in the United Kingdom is a rational outcome of the drug’s anti-inflammatory effects, experts say.

Using optogenetics, scientists have simulated the sense of smell directly within the mouse brain to investigate the nature of olfactory perception.

Lacking many diagnostic test results from the first major outbreak, researchers have been left to scour other sources for clues about what happened in the early days of the pandemic.

The agreement will include approximately 2,700 journals as well as plans to transition Nature journals to open access for the University of California system.

The company behind a now-discredited study on hydroxychloroquine also posted a report that has been cited by Latin American governments recommending ivermectin as a possible coronavirus treatment. Clinicians there say the effects have been extremely damaging.

Hydroxychloroquine and chloroquine, once thought to be promising COVID-19 treatments, come with serious heart risks.

A study of 34 children hospitalized with a coronavirus infection in China reveals that fever and coughing were common, but the type of lesions typically seen in the lungs of adults with COVID-19 were rare.

The upcoming summer research season has been suspended amid the COVID-19 pandemic.

Accounting for a limited stockpile of cholera vaccine can provide insight into the most effective way to distribute future COVID-19 vaccines.